Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase

FEBS Lett. 1984 Dec 3;178(1):83-6. doi: 10.1016/0014-5793(84)81245-4.

Abstract

Two human glucagon-like peptides, GLP-1 and GLP-2, which are coencoded with pancreatic glucagon in the preproglucagon gene, do not significantly inhibit [125I]monoiodoglucagon binding to rat liver and brain membranes and do not activate adenylate cyclase in liver plasma membranes. Nevertheless, GLP-1 and GLP-2 were each found to be potent stimulators of both rat hypothalamic and pituitary adenylate cyclase. Only 30-50 pM concentrations of each peptide elicited half-maximal adenylate cyclase stimulation. Our data suggest that GLP-1 and GLP-2 may be neurotransmitters and/or neuroendocrine effectors, which would account for their high degree of sequence conservation through vertebrate evolution.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenylyl Cyclases / metabolism*
  • Brain / drug effects
  • Brain / enzymology*
  • Dose-Response Relationship, Drug
  • Enzyme Activation
  • Glucagon / analogs & derivatives
  • Glucagon / metabolism
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide 2
  • Humans
  • Peptides / pharmacology*
  • Receptors, Cell Surface / metabolism
  • Receptors, Glucagon

Substances

  • Glucagon-Like Peptide 2
  • Peptides
  • Receptors, Cell Surface
  • Receptors, Glucagon
  • iodoglucagon
  • Glucagon-Like Peptide 1
  • Glucagon
  • Adenylyl Cyclases